ImmunoCellular Therapeutics
Public:
Nasdaq: IMUC
Headquarters:
Calabasas, CA
Deal Team:
Lou Lange
Developer of active immunotherapies to target regular tumor cells as well as cancer stem cells believed to cause cancer growth and reoccurrence
AMV
AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.
2100 Geng Road, Suite 200
Palo Alto, CA
650.621.8808
© 2019 Asset Management Ventures
All Rights Reserved